32nd ICPE, 2016 in Dublin

Update from Day 4

This conference has been very rich in terms of the diversity and depth of presentations. It is exciting to see the developments ongoing in our discipline as we develop the best ways to measure, monitor and manage the benefit-risk of medicines across the whole lifecycle of products.

The conference highlight for me from today was the plenary session on incorporating the patient perspective into clinical and pharmacoepidemiological research. The patient, academic and industry presentations captured the different perspectives and highlighted where we are on the journey of moving from “why” to “how” we incorporate the patient perspective.

2 quotes from the slide presentations are provided below

“Since patients will be the ones taking these medicines it makes absolute sense to incorporate their values and their knowledge at different stages throughout the long process of developing assessing, licensing and monitoring medicines”

 Isabelle Moulon EMA

It turns out that what is really bothering the patient and what is really bothering the doctor can be radically different things.”

Janet Woodcock, M.D. Director, Center for Drug Evaluation and Research FDA

IMG_0040

 

Other highlights from today included the early morning walk down to Trinity College and a meal on the boat MV Cill Airne Boat Bar and Restaurant pictured in the collage above

 

Advertisements

32nd ICPE, Dublin

I’m very excited to be at the 32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management in Dublin. I’m looking forward to 5 days of stimulating discussion, good speakers and workshops as well as meeting old (and making new) friends. More to follow on this.

This is the week I launch my new Pharmacovigilance and Risk Management consultancy company, Wise Pharmacovigilance and Risk Management Limited (www.wise-pvrm.com). For further information view the Home Page or press the “contact us” tab on the website links to send me an email.

WiseTeal